Evidence map›Paper›PMID 18254958›Full record

ArticleBMC genomics2008

Transcriptomic dissection of tongue squamous cell carcinoma.

Hui Ye, Tianwei Yu, Stephane Temam, Barry L Ziober, Jianguang Wang, Joel L Schwartz, Li Mao, David T Wong, Xiaofeng Zhou

Abstract read
In one paragraph

Article in BMC genomics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 183 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
183citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

183 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.Journal of the National Cancer Institute · 2018
    Trial
  9. Trial
  10. Gene expression profiling predicts the development of oral cancer.Cancer prevention research (Philadelphia, Pa.) · 2011
    Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

123 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hui YeCenter for Molecular Biology of Oral Diseases, College of Dentistry, University of Illinois at Chicago, Chicago, IL, USA. huiye@uic.edu
Tianwei Yu
Stephane Temam
Barry L Ziober
Jianguang Wang
Joel L Schwartz
Li Mao
David T Wong
Xiaofeng Zhou

Funding

TARGETING COX-2 AND EGFR SIGNALING IN ORAL CARCINOGENESISP01CA106451 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LIPPMAN, SCOTT M · 2004 to 2009
$8.3M
Genomics and Proteomics of Oral Precancer ProgressionR01DE015970 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, DAVID T · 2004 to 2009
$1.9M
Genomic Predictors of Oral Premalignancy ProgressionK22DE014847 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ZHOU, XIAOFENG · 2004 to 2009
$619k
Expression-based identification of OHNC genomic changesR03DE016569 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ZHOU, XIAOFENG · 2005 to 2006
$304k
Molecular Determinants of Oral Cancer DetectionR03CA114688 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ZHOU, XIAOFENG · 2005 to 2006
$153k
NCI NIH HHS P01 CA106451NCI NIH HHS R03 CA114688NIDCR NIH HHS K22 DE014847NIDCR NIH HHS R01 DE015970NIDCR NIH HHS R03 DE016569
6 · The paper itself

Abstract

backgroundThe head and neck/oral squamous cell carcinoma (HNOSCC) is a diverse group of cancers, which develop from many different anatomic sites and are associated with different risk factors and genetic characteristics. The oral tongue squamous cell carcinoma (OTSCC) is one of the most common types of HNOSCC. It is significantly more aggressive than other forms of HNOSCC, in terms of local invasion and spread. In this study, we aim to identify specific transcriptomic signatures that associated with OTSCC.

resultsGenome-wide transcriptomic profiles were obtained for 53 primary OTSCCs and 22 matching normal tissues. Genes that exhibit statistically significant differences in expression between OTSCCs and normal were identified. These include up-regulated genes (MMP1, MMP10, MMP3, MMP12, PTHLH, INHBA, LAMC2, IL8, KRT17, COL1A2, IFI6, ISG15, PLAU, GREM1, MMP9, IFI44, CXCL1), and down-regulated genes (KRT4, MAL, CRNN, SCEL, CRISP3, SPINK5, CLCA4, ADH1B, P11, TGM3, RHCG, PPP1R3C, CEACAM7, HPGD, CFD, ABCA8, CLU, CYP3A5). The expressional difference of IL8 and MMP9 were further validated by real-time quantitative RT-PCR and immunohistochemistry. The Gene Ontology analysis suggested a number of altered biological processes in OTSCCs, including enhancements in phosphate transport, collagen catabolism, I-kappaB kinase/NF-kappaB signaling cascade, extracellular matrix organization and biogenesis, chemotaxis, as well as suppressions of superoxide release, hydrogen peroxide metabolism, cellular response to hydrogen peroxide, keratinization, and keratinocyte differentiation in OTSCCs.

conclusionIn summary, our study provided a transcriptomic signature for OTSCC that may lead to a diagnosis or screen tool and provide the foundation for further functional validation of these specific candidate genes for OTSCC.

Indexed as

Gene Expression ProfilingAdultAgedAged, 80 and overBase SequenceBiomarkersCarcinoma, Squamous CellCase-Control StudiesCollagenDNA PrimersFemaleHumansImmunohistochemistryInterleukin-8MaleMatrix Metalloproteinase 9BiomarkersCollagenCXCL8 protein, humanDNA PrimersInterleukin-8Matrix Metalloproteinase 9RNA, MessengerRNA, Neoplasm

Identifiers

PMID18254958
PMCPMC2262071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.